Print this page    •   Back to Web version of article

U.S. News
FDA Clears Integrated System to Screen Widely for Hepatitis B

July 19, 2006

A new system to screen blood, tissue and organ donors for hepatitis B has been approved by the Food and Drug Administration. The system, which combines two tests from Abbott Laboratories, tests blood samples for the presence of hepatitis B surface antigen, then confirms the infection. It can also screen blood from cadavers for organ and tissue donation. The test is tamper-resistant and fully automated, FDA said, reducing the possibility of operator error. "Improvements in blood donor screening and testing over the last few years have helped make the nation's blood supply safer from infectious diseases than it has been at any other time," said Jesse Goodman, director of FDA's Center for Biologics Evaluation and Research.

Back to other news for July 19, 2006

Excerpted from:
Wall Street Journal
07.19.06; Jennifer Corbett Dooren




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art23773.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.